Tags |
|
|
Links |
|
|
Digg It - Are Expectations and Boundaries Clearly In Place?
Watching young children at play is, of course, entertaining. For the businessperson, watching young children
According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product
at play can also be educational. Sometimes kids run amok; they can be aggressive, destructive, and unmanage
; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.
Examples of combination products may in
Examples of combination products may in
ble yet n other situations they are orderly, polite, and delightful. I don’t think the difference has anythi
lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.
g to do with the way the planets are aligned. I think the difference is that, in the latter instance, parent
here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe
and educators have established expectations and boundaries, they have communicated them clearly, and follow
d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.
Combination pro
Combination pro
p to insure those expectations and boundaries are met. When youngsters know what is expected of them, what t
ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc
ey may or may not do, most rise to the challenge. In a broad generalization, when expectations and boundarie
easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi
s have been established the children have an increased ability to learn and communicate, they become more pro
nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically
uctive and accomplished.
The reason this is educational for the businessperson is that the same holds throug
The reason this is educational for the businessperson is that the same holds throug
and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ
in every aspect of managing a business. It’s all about expectations and boundaries, communication and follo
ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi
-through.
If we clearly communicate our expectations and boundaries to vendors, staff, and customers and the
If we clearly communicate our expectations and boundaries to vendors, staff, and customers and the
ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.
Following aspects would a
Following aspects would a
follow up with them to insure our expectations and boundaries are met, the business will not descend into ch
dd to the challenges in developing combination products:
Which markets to tap where the combination products can do fairly well?
Which combination prod
Which markets to tap where the combination products can do fairly well?
Which combination prod
os. It too will become more productive and accomplished. Quality of the work, customer satisfaction, and mo
cts are meaningful and rational?
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin
ale will be higher. These translate into a happier staff, higher quality of work performance, higher rates o
tions increase the patient compliance?
What would be the developing cost?
How to tackle the risks encountered during combination product developmen
What would be the developing cost?
How to tackle the risks encountered during combination product developmen
f staff and customer retention, and vendors who will bend over backwards to please you.
Now, I’m not suggest
Now, I’m not suggest
t?
As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
ng that parents and educators or managers and supervisors should rule their domains like wardens running a pr
ping new procedures for reviewing their safety, efficacy and quality.
Professional from academic institutions, pharmaceutical industries, health care indust
Professional from academic institutions, pharmaceutical industries, health care indust
son exercise yard. I’m advocating treating people with respect, understanding, acknowledging their intellige
y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products
ce and humanity. Most will rise to the occasion. If you are experiencing difficulty in managing any aspect
.
As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
f your business where people are involved, before going off on a rampage, first look at the expectations you
elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.
Companies that provide selfless information through particip
Companies that provide selfless information through particip
ave communicated and the boundaries you have established and see whether they need to be more clearly defined
tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
<a href="http://www.diggit.org.ua/article/23350/diggit-Are-Expectations-and-Boundaries-Clearly-In-Place.html">Are Expectations and Boundaries Clearly In Place?</a>
BB link (for phorums):
[url=http://www.diggit.org.ua/article/23350/diggit-Are-Expectations-and-Boundaries-Clearly-In-Place.html]Are Expectations and Boundaries Clearly In Place?[/url]
Related Articles:
Bookmark it:
|